- Home
- GDYN vs AMLX Comparison
GDYN vs AMLX Comparison
Compare GDYN & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- AMLX
- Stock Information
- Founded
- GDYN 2006
- AMLX 2014
- Country
- GDYN United States
- AMLX United States
- Employees
- GDYN N/A
- AMLX N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- GDYN Technology
- AMLX Health Care
- Exchange
- GDYN Nasdaq
- AMLX Nasdaq
- Market Cap
- GDYN 652.8M
- AMLX 749.9M
- IPO Year
- GDYN N/A
- AMLX 2022
- Fundamental
- Price
- GDYN $8.33
- AMLX $14.82
- Analyst Decision
- GDYN Strong Buy
- AMLX Strong Buy
- Analyst Count
- GDYN 5
- AMLX 7
- Target Price
- GDYN $14.80
- AMLX $15.14
- AVG Volume (30 Days)
- GDYN 1.3M
- AMLX 2.0M
- Earning Date
- GDYN 10-30-2025
- AMLX 11-06-2025
- Dividend Yield
- GDYN N/A
- AMLX N/A
- EPS Growth
- GDYN N/A
- AMLX N/A
- EPS
- GDYN 0.19
- AMLX N/A
- Revenue
- GDYN $389,227,000.00
- AMLX N/A
- Revenue This Year
- GDYN $20.78
- AMLX N/A
- Revenue Next Year
- GDYN $10.71
- AMLX N/A
- P/E Ratio
- GDYN $42.93
- AMLX N/A
- Revenue Growth
- GDYN 22.27
- AMLX N/A
- 52 Week Low
- GDYN $7.37
- AMLX $2.60
- 52 Week High
- GDYN $25.50
- AMLX $15.16
- Technical
- Relative Strength Index (RSI)
- GDYN 52.29
- AMLX 69.32
- Support Level
- GDYN $7.98
- AMLX $12.35
- Resistance Level
- GDYN $8.64
- AMLX $13.75
- Average True Range (ATR)
- GDYN 0.37
- AMLX 0.95
- MACD
- GDYN 0.09
- AMLX -0.13
- Stochastic Oscillator
- GDYN 67.90
- AMLX 93.93
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.